摘要
目的探讨巴曲酶与银杏达莫联合治疗脑梗死的疗效研究。方法选取2017年9月—2018年9月我院收治的脑梗死患者62例作为研究对象,将其随机分为两组。对照组应用巴曲酶治疗,研究组应用巴曲酶与银杏达莫联合治疗。比较两组患者治疗效果、梗死面积与NIHSS评分。结果研究组患者的治疗效果优于对照组,差异具有统计学意义(P <0.05);治疗后,研究组梗死面积低于对照组,NIHSS评分、生活能力评分高于对照组,差异具有统计学意义(P <0.05)。结论巴曲酶与银杏达莫联合治疗脑梗死,效果显著,可有效降低梗死面积,提高生活质量,临床价值高。
Objective To investigate the efficacy of batroxobin combined with ginkgo biloba-damo in the treatment of cerebral infarction. Methods 62 patients with cerebral infarction admitted to our hospital from September 2017 to September 2018 were randomly divided into two groups. The control group was treated with batroxobin, while the study group was treated with batroxobin and ginkgo biloba-damo. The therapeutic effect, infarct size and NIHSS score were compared between the two groups. Results The treatment effect of the study group was better than that of the control group, the difference was statistically significant(P<0.05). After treatment, the infarct size of the study group was lower than that of the control group, and the NIHSS score and life ability score were higher than the control group, the difference was statistically significant(P<0.05).Conclusion Batroxobin combined with ginkgo biloba-damo in the treatment of cerebral infarction has significant effect, can effectively reduce infarct size, improve quality of life, high clinical value.
作者
张华芹
ZHANG Huaqin(Department of Internal Medicine, Yichang Central People's Hospital, Yichang Hubei 443000, China)
出处
《中国继续医学教育》
2019年第14期160-162,共3页
China Continuing Medical Education
关键词
巴曲酶
银杏达莫
脑梗死
疗效
防止
研究
batroxobin
ginkgo biloba-damo
cerebral infarction
therapeutic effect
prevention
research
